Tulane University researchers have developed a new drug that is effective against non-severe cases of malaria, according to results from an FDA-supervised clinical trial published online in The Lancet Infectious Diseases.
The results are significant as public health experts have long warned that the parasite responsible for most malaria cases, Plasmodium falciparum, is developing resistance to widely used treatments. New medications are needed to build up secondary defenses against drug-resistant strains of the parasite.
The drug, called AQ-13, was able to clear the parasite responsible for the disease within a week, matching the effectiveness of the most widely used treatment regimen.
“The potential long-term implications are bigger than one drug. The conceptual step here is that if you understand the resistance well enough, you may be actually be able to develop others as well.”
Dr. Donald Krogstad
“The clinical trial results are extraordinarily encouraging,” said Dr. Donald Krogstad, senior author and professor of tropical medicine at Tulane University School of Public Health and Tropical Medicine. “Compared to the current first-line recommendation for treatment of malaria, the new drug comes out very well.”
Mosquitoes infected by a parasite spread malaria, causing more than 200 million illnesses across the globe and more than 400,000 deaths annually. For decades, chloroquine was used to treat malaria until Plasmodium falciparum developed resistance. Now, a drug combination — artemether and lumefantrine — is the primary treatment for malaria although resistance is also developing to the drug combination in some countries.
Researchers recruited 66 adult men in Mali with uncomplicated malaria, which is defined as malaria that isn’t life threatening. Half were treated with AQ-13 and the other half received artemether and lumefantrine. Both drug groups had similar cure rates. However, five participants in AQ-13 group left the study or were lost to follow-up and two participants in the artemether/lumefantrine group had late treatment failures with recurrence of their original infections.
Researchers hope to expand testing of the drug to more participants, including women and children, before it can be widely recommended as a new treatment. Krogstad said that the same biotechnology that helped the team develop the new drug has also identified similar drugs that also hold promise against drug-resistant parasites.
The Latest on: Malaria
New understanding of parasite biology might help stop malaria transmission
on March 15, 2018 at 1:05 pm
Researchers made an important step toward deeper understanding of how malaria blood stage parasites turn the switch to become transmissible to other humans. This knowledge is fundamental for future research aiming to interrupt malaria transmission. […]
WATCH - New Animation Looks at History Of Malaria
on March 14, 2018 at 10:15 pm
Award-winning studio Aardman has teamed up with the global campaign, Malaria Must Die So Millions Can Live, to call on leaders to "unite and fight" the disease that takes the life of a child every two minutes. The animation, voiced by actor Hugh Laurie ... […]
Johns Hopkins scientists genetically engineer malaria-resistant mosquitoes
on March 13, 2018 at 5:34 am
Mosquitoes are bad news when it comes to the spread of malaria, a deadly disease which kills hundreds of thousands of people each year. We previously covered a range of approaches to cracking down on this problem — ranging from apps which track disease ... […]
Aardman and Hugh Laurie Target Malaria in Animated PSA
on March 12, 2018 at 12:17 pm
Award-winning studio Aardman has joined forces with global campaign Malaria Must Die So Millions Can Live to raise awareness of the disease’s deadly history, and call for decisive action by world leaders to “unite and fight” the devastating parasite ... […]
How One Child’s Sickle Cell Mutation Helped Protect the World From Malaria
on March 9, 2018 at 2:14 pm
Thousands of years ago, a special child was born in the Sahara. At the time, this was not a desert; it was a green belt of savannas, woodlands, lakes and rivers. Bands of hunter-gatherers thrived there, catching fish and spearing hippos. A genetic mutation ... […]
Malaria-resistant mosquitoes engineered using CRISPR
on March 8, 2018 at 11:11 pm
The gene-editing tool CRISPR/Cas9 has been used to engineer malaria-resistant mosquitoes(Credit: mrfiza/Depositphotos) Swatting at mosquitoes is a great start, but if we really want to cut down on the hundreds of millions of malaria cases they cause every ... […]
How the Fight Against Malaria Infected the Future Map of Israel
on March 5, 2018 at 6:49 am
Dr. Zalman Greenberg, a Jerusalem microbiologist who is now retired from the Ministry of Health, has spent years researching the history of medicine in Israel. Twenty years ago he started compiling an extensive bibliography of microbiology studies done in ... […]
via Google News and Bing News